Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030305 (
pancreatitis
)
16,014
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Coxsackievirus B3 (CVB3) is a causative agent of viral myocarditis, hepatitis,
pancreatitis
, and meningitis in humans. The adenosine-uridine (AU)-rich element RNA binding factor 1 (
AUF1
) is an integral component in the regulation of gene expression.
AUF1
destabilizes mRNAs and targets them for degradation by binding to AU-rich elements in the 3' untranslated region (UTR) of mRNAs. The 3'-UTR of the CVB3 genome contains canonical AU-rich sequences, raising the possibility that CVB3 RNA may also be subjected to
AUF1
-mediated degradation. Here, we reported that CVB3 infection led to cytoplasmic redistribution and cleavage of
AUF1
. These events are independent of CVB3-induced caspase activation but require viral protein production. Overexpression of viral protease 2A reproduced CVB3-induced cytoplasmic redistribution of
AUF1
, while in vitro cleavage assay revealed that viral protease 3C contributed to
AUF1
cleavage. Furthermore, we showed that knockdown of
AUF1
facilitated viral RNA, protein, and progeny production, suggesting an antiviral property for
AUF1
against CVB3 infection. Finally, an immunoprecipitation study demonstrated the physical interaction between
AUF1
and the 3'-UTR of CVB3, potentially targeting CVB3 genome toward degradation. Together, our results suggest that cleavage of
AUF1
may be a strategy employed by CVB3 to enhance the stability of its viral genome.
...
PMID:Cytoplasmic redistribution and cleavage of AUF1 during coxsackievirus infection enhance the stability of its viral genome. 2357 32